Worldwide sales rose about 18 percent to reach $8.8 billion, fueled in part by strong sales of the drug Humira, which treats rheumatoid arthritis, and a 34 percent rise in global sales of coronary stents, such as Xience. Global stent sales soared to $533 million dollars, the company said.
Abbott expects to hit its previous guidance of full-year earnings of $4.13 to $4.18 per share. The midpoint is a 12 percent increase over 2009.
Ad Statistics
Times Displayed: 48032
Times Visited: 1363 Ampronix, a Top Master Distributor for Sony Medical, provides Sales, Service & Exchanges for Sony Surgical Displays, Printers, & More. Rely on Us for Expert Support Tailored to Your Needs. Email info@ampronix.com or Call 949-273-8000 for Premier Pricing.
Abbott rose 1.2 percent to reach $49.25 in recent trading.
Back to HCB News
